Suppr超能文献

OCT4 在人食管鳞癌中的表达与预后不良显著相关。

Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.

机构信息

Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.

出版信息

World J Gastroenterol. 2012 Feb 21;18(7):712-9. doi: 10.3748/wjg.v18.i7.712.

Abstract

AIM

To explore the expression pattern of OCT4 in human esophageal squamous cell carcinoma and its significance in diagnosis and prognosis.

METHODS

Using real-time polymerase chain reaction (PCR), Western blotting, immunocytochemistry and immunohistochemistry, the expression of OCT4 in three esophageal squamous cancer cell lines, KYSE70, KYSE140 and KYSE450, was characterized. OCT4 expression was investigated in a series of 153 esophageal squamous cell carcinoma samples using immunohistochemistry and explored its association with clinicopathological features.

RESULTS

Immunohistochemically, OCT4 positive immunostaining was observed in cancer cell nuclei. OCT4 was variably expressed in three esophageal squamous cancer cell lines. Among 153 specimens, 105 (68.7%) were negative or weakly positive for OCT4 staining; 21 (13.7%) were moderately positive and 27 (17.6%) were strongly positive. Higher expression level of OCT4 was significantly associated with higher histological grade (P < 0.001) and poor clinic outcome (P < 0.001).

CONCLUSION

The expression of OCT4 enables the tumor to have a higher degree of stemness, which in turn results in a poorer clinical outcome for patients with esophageal squamous cell carcinoma.

摘要

目的

探讨 OCT4 在人食管鳞癌中的表达模式及其在诊断和预后中的意义。

方法

采用实时聚合酶链反应(PCR)、Western blot、免疫细胞化学和免疫组织化学技术,对 3 种食管鳞癌细胞系 KYSE70、KYSE140 和 KYSE450 中 OCT4 的表达进行了鉴定。采用免疫组织化学方法检测了 153 例食管鳞癌标本中 OCT4 的表达,并探讨了其与临床病理特征的关系。

结果

免疫组化染色显示 OCT4 在癌细胞核中呈阳性表达。OCT4 在 3 种食管鳞癌细胞系中呈不同程度的表达。在 153 例标本中,105 例(68.7%) OCT4 染色阴性或弱阳性;21 例(13.7%)中度阳性,27 例(17.6%)强阳性。OCT4 表达水平较高与组织学分级较高(P < 0.001)和临床预后不良(P < 0.001)显著相关。

结论

OCT4 的表达使肿瘤具有更高的干性,进而导致食管鳞癌患者的临床预后较差。

相似文献

1
Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.
World J Gastroenterol. 2012 Feb 21;18(7):712-9. doi: 10.3748/wjg.v18.i7.712.
5
Over-expression of Oct4 in human esophageal squamous cell carcinoma.
Mol Cells. 2011 Jul;32(1):39-45. doi: 10.1007/s10059-011-2315-5. Epub 2011 May 3.
6
XAF1 is frequently methylated in human esophageal cancer.
World J Gastroenterol. 2012 Jun 14;18(22):2844-9. doi: 10.3748/wjg.v18.i22.2844.
8
Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
Tumour Biol. 2016 Jun;37(6):7139-48. doi: 10.1007/s13277-015-4459-y. Epub 2015 Dec 12.
10
Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.
Cell Mol Biol Lett. 2017 Dec 29;22:33. doi: 10.1186/s11658-017-0065-x. eCollection 2017.

引用本文的文献

1
OCT4 and MENA immunoprofiling in salivary mucoepidermoid carcinoma.
Diagn Pathol. 2025 May 27;20(1):67. doi: 10.1186/s13000-025-01665-8.
2
Expression of Pluripotency Factors OCT4 and LIN28 Correlates with Survival Outcome in Lung Adenocarcinoma.
Medicina (Kaunas). 2024 May 26;60(6):870. doi: 10.3390/medicina60060870.
3
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter.
Int J Mol Sci. 2023 Dec 29;25(1):496. doi: 10.3390/ijms25010496.
4
Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma.
Cancers (Basel). 2022 Apr 22;14(9):2095. doi: 10.3390/cancers14092095.
5
Research progress of cancer stem cells and IL-6/STAT3 signaling pathway in esophageal adenocarcinoma.
Transl Cancer Res. 2020 Jan;9(1):363-371. doi: 10.21037/tcr.2019.11.12.
7
Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
Medicine (Baltimore). 2020 Oct 16;99(42):e22804. doi: 10.1097/MD.0000000000022804.
8
Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
Cancer Med. 2020 Dec;9(23):8782-8800. doi: 10.1002/cam4.3486. Epub 2020 Sep 26.
9
Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis.
J Cancer. 2020 Apr 27;11(14):4240-4249. doi: 10.7150/jca.33699. eCollection 2020.
10
Role of OCT4 in cancer stem-like cells and chemotherapy resistance.
Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165432. doi: 10.1016/j.bbadis.2019.03.005. Epub 2019 Mar 21.

本文引用的文献

1
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell. 2007 Nov 30;131(5):861-72. doi: 10.1016/j.cell.2007.11.019.
2
Absence of OCT4 expression in somatic tumor cell lines.
Stem Cells. 2008 Mar;26(3):692-7. doi: 10.1634/stemcells.2007-0657. Epub 2007 Nov 21.
3
Induced pluripotent stem cell lines derived from human somatic cells.
Science. 2007 Dec 21;318(5858):1917-20. doi: 10.1126/science.1151526. Epub 2007 Nov 20.
4
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy.
J Exp Med. 2007 Apr 16;204(4):831-40. doi: 10.1084/jem.20062387. Epub 2007 Mar 26.
6
Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model.
Pancreatology. 2006;6(4):406-13. doi: 10.1159/000094317. Epub 2006 Jun 29.
7
Retroperitoneal seminoma in limited biopsies: morphologic criteria and immunohistochemical findings in 30 cases.
Am J Surg Pathol. 2006 Jun;30(6):766-73. doi: 10.1097/00000478-200606000-00015.
9
Oct4 pseudogenes are transcribed in cancers.
Biochem Biophys Res Commun. 2005 Dec 2;337(4):1047-51. doi: 10.1016/j.bbrc.2005.09.157. Epub 2005 Oct 4.
10
Regulatory networks in embryo-derived pluripotent stem cells.
Nat Rev Mol Cell Biol. 2005 Nov;6(11):872-84. doi: 10.1038/nrm1744.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验